Pharmaceutical Regulatory Affairs: Open Access

Title Publication Date Language Citations
Antibiotic Abuse in Developing Countries2012/01/0127
AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease2014/01/0115
http://www.omicsgroup.org/journals/conotoxins-and-their-regulatory-considerations-2167-7689.1000122.php?aid=302262014/01/017
Marijuana Toxicity: Heavy Metal Exposure Through State-Sponsored Access to “la Fee Verte”2018/01/017
Malaysian Cosmetic Market: Current and Future Prospects2015/01/016
The Three-Level Approach: A Framework for Ensuring Medicines Quality in Limited-Resource Countries2014/01/015
Pharma Regulations for Generic Drug Products in India and US: Case Studies and Future Prospectives2014/01/015
Does the Requirement of Readability Testing Improve Package Leaflets? Evaluation of the 100 Most Frequently Prescribed Drugs in Germany Marketed before 2005 and First Time in 2007 or After2012/01/015
Impact of API (Active Pharmaceutical Ingredient) Source Selection on Generic Drug Products2015/01/014
Future Prospective of Cancer Vaccination Technology in Japan2015/01/014
Europe - New regulations - What impact will the proposed new regulations in Europe have for medical device manufacturer?2013/01/014
E-pharmacies Regulation in India: Bringing New Dimensions to Pharma Sector2016/01/013
Medical Devices Regulation in United States of America, European Union and India: A Comparative Study2017/01/013
Ever-greening in Pharmaceuticals: Strategies, Consequences and Provisions for Prevention in USA, EU, India and Other Countries2017/01/013
The Use of Medicinal Plants in Human Healthcare: A Scoop on Safety2014/01/013
Is SteradR from J&J is Truly Plasma Gas Sterilizer?2014/01/013
Regulations on Adaptive Design Clinical Trials2014/01/013
Screening of Compounds from an FDA-Approved Drug Library for the Ability to Inhibit Aspartic Protease Secretion from the Pathogenic Yeast Candida albicans2014/01/013
Post Marketing Surveillance of Anti-malarial Medicines in Tanzania2017/01/013
Current Mistaken Interpretation of Microbiological Data on Gas Plasma Sterilization2015/01/012
Comparison on Safety Concern Among Gamma-Ray, Autoclave and Ethylene Oxide Gas Sterilizations of Thermosetting Polyurethane2014/01/012
Health Hazards in the Pharmaceutical Industry2015/01/012
Responsibility of Regulatory Affairs in Pharmaceutical Industry2016/01/012
Harmonized Guideline on Limit and Testing of Elemental Impurities in Pharmaceutical Substances: A Review2016/01/012
Simultaneous RP-HPLC Method Development and Validation of Atorvastatin, Ezetimibe and Fenofibrate2016/01/012
Development of Innovative Medicines for European Patients and Impact of Brexit2016/01/012
Biosimilars: an Emerging Market Opportunities in India2016/01/012
Pharmaceutical Good Manufacturing Practice Regulatory Affairs in Sudan: Continuous Debate between Regulatory Authority and Manufacturers2016/01/012
Simultaneous Achievement of Sterility Assurance Level (SAL) of 10-6 and Material and Functional Compatibility in Gas Plasma Sterilization2015/01/012
FDA Regulation of Medical Devices and Medical Device Reporting2013/01/012